Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study
- 2 February 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Cancer Survivorship
- Vol. 7 (2), 191-202
- https://doi.org/10.1007/s11764-012-0258-2
Abstract
Introduction Risk factors for employment difficulties after cancer diagnosis are incompletely understood, and interventions to improve post-cancer employment remain few. New targets for intervention are needed. Methods We assessed a cohort of 530 nonmetastatic cancer patients (aged ≤ 65 years, >6 months from diagnosis, off chemo- or radiotherapy) from the observational multi-site Symptom Outcomes and Practice Patterns study. Participants reported employment change, current employment, and symptoms. Groups were based on employment at survey (working full- or part-time versus not working) and whether there had been a change due to illness (yes versus no). The predictive power of symptom interference with work was evaluated for employment group (working stably versus no longer working). Race/ethnicity, gender, cancer type, therapy, and time since diagnosis were also assessed. Association between employment group and specific symptoms was examined. Results The cohort was largely non-Hispanic white (76 %), female (85 %), and diagnosed with breast cancer (75 %); 24 % reported a change in employment. On multivariable analysis, participants with at least moderate symptom interference were more likely to report no longer working than their less effected counterparts (odds ratio (OR) = 8.0, 95 % CI, 4.2–15.4), as were minority participants compared with their non-Hispanic white counterparts (OR = 3.2, 95 % CI, 1.8–5.6). Results from the multiple regression model indicated the combination of fatigue (OR = 2.3, 95 % CI, 1.1–4.7), distress (OR = 3.9, 95 % CI, 1.7–9.0), and dry mouth (OR = 2.6, 95 % CI, 1.1–6.2) together with race/ethnicity and time since diagnosis adequately accounted for employment group. Conclusions Our findings support the hypothesis that residual symptom burden is related to post-cancer employment: Residual symptoms may be targets for intervention to improve work outcomes among cancer survivors. Implications for Cancer Survivors This analysis examines whether increased symptom burden is associated with a change to not working following a cancer diagnosis. We also examined individual symptoms to assess which symptoms were most strongly associated with not working after a cancer diagnosis. Our hope is that we will be able to use this information to both screen survivors post-active treatment as well as target high-risk symptoms for further and more aggressive intervention, in an attempt to improve post-cancer work outcomes.Keywords
This publication has 66 references indexed in Scilit:
- Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate CancerJournal of Clinical Oncology, 2012
- Cancer Survivors: A Booming PopulationCancer Epidemiology, Biomarkers & Prevention, 2011
- Symptom burden in cancer survivors 1 year after diagnosisCancer, 2011
- Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care responseJournal of Cancer Survivorship, 2009
- Factors influencing changes in employment among women with newly diagnosed breast cancerCancer, 2009
- An Individualized Representational Intervention to Improve Symptom Management (IRIS) in Older Breast Cancer Survivors: Three Pilot StudiesOncology Nursing Forum, 2009
- Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time?Journal of Pain and Symptom Management, 2009
- Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and SymptomsJournal of Clinical Oncology, 2009
- Work ability and return-to-work in cancer patientsBritish Journal of Cancer, 2008
- Safety of aromatase inhibitors in the adjuvant settingBreast Cancer Research and Treatment, 2007